On Day 28, the levels of IFN-γ, IL-1α and IL-17α in the sera of the BLM + MHA, BLM + HHA, and BLM + MIX HA groups were significantly lower than those in the BLM group. The gene discussed is MIXL1; the disease is Bloom syndrome.